Kitch Wilson
Private Equity Investor bij Pioneer Fund/NY/
Actieve functies van Kitch Wilson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Pioneer Fund/NY/
 Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Private Equity Investor | 01-10-2023 | - |
Loopbaan van Kitch Wilson
Eerdere bekende functies van Kitch Wilson
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Bell Biosystems, Inc.
 Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Consultant / Adviseur | 01-01-2011 | 01-04-2014 |
Opleiding van Kitch Wilson
| Stanford University | Graduate Degree |
| Duke University School of Medicine | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Graduate Degree | 2 |
| Private Equity Investor | 1 |
| Consultant / Advisor | 1 |
Sectoraal
| Consumer Services | 3 |
| Finance | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Pioneer Fund/NY/
Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Finance |
Bell Biosystems, Inc.
Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Health Technology |
- Beurs
- Insiders
- Kitch Wilson
- Ervaring
